Effects of lorazepam and diazepam on conscious and automatic memory processes. 1996

P Vidailhet, and M Kazès, and J M Danion, and F Kauffmann-Muller, and D Grangé
INSERM Unité 405, Département de Psychiatrie, Hôpitaux Universitaires de Strasbourg, France.

Recent studies exploring benzodiazepine memory effects have used the distinction between explicit and implicit tasks. There is now increasing evidence that implicit tasks can be "contaminated" by conscious uses of memory and that unconscious (automatic) use of memory can contaminate explicit tasks, leading to mistaken estimates of their respective influences on memory performance. The aim of the present double-blind, double-placebo study was to assess the memory effects of diazepam and lorazepam using a process-dissociation procedure in a stem-completion task, this procedure providing uncontaminated estimates of conscious and automatic memory processes. The memory task was administrated to 60 healthy volunteers randomly assigned to one of three parallel groups (placebo, diazepam 0.3 mg/kg, lorazepam 0.038 mg/kg). Lorazepam markedly reduced conscious as well as automatic influences of memory. Diazepam also reduced conscious uses of memory, albeit to a lesser extent than lorazepam, but did not decrease the influence of automatic memory. Secondary analyses showed that when the deleterious effect on conscious uses of memory was equated between a diazepam subgroup and the lorazepam group, only lorazepam impaired the automatic use of memory. This study strongly suggests a qualitative difference in the memory effects of the two benzodiazepines. It has some implications regarding the relationships between states of consciousness and memory processes.

UI MeSH Term Description Entries
D008140 Lorazepam A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent. Apo-Lorazepam,Ativan,Donix,Duralozam,Durazolam,Idalprem,Laubeel,Lorazep Von Ct,Lorazepam Medical,Lorazepam-Neuraxpharm,Lorazepam-Ratiopharm,Novo-Lorazem,Nu-Loraz,Orfidal Wyeth,Sedicepan,Sinestron,Somagerol,Temesta,Tolid,Témesta,WY-4036,Apo Lorazepam,Lorazepam Neuraxpharm,Lorazepam Ratiopharm,Medical, Lorazepam,Novo Lorazem,Nu Loraz,Von Ct, Lorazep,WY 4036,WY4036,Wyeth, Orfidal
D008297 Male Males
D008568 Memory Complex mental function having four distinct phases: (1) memorizing or learning, (2) retention, (3) recall, and (4) recognition. Clinically, it is usually subdivided into immediate, recent, and remote memory.
D011939 Mental Recall The process whereby a representation of past experience is elicited. Recall, Mental
D003071 Cognition Intellectual or mental process whereby an organism obtains knowledge. Cognitive Function,Cognitions,Cognitive Functions,Function, Cognitive,Functions, Cognitive
D003243 Consciousness Sense of awareness of self and of the environment. Consciousnesses
D003975 Diazepam A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity. 7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one,Apaurin,Diazemuls,Faustan,Relanium,Seduxen,Sibazon,Stesolid,Valium
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

P Vidailhet, and M Kazès, and J M Danion, and F Kauffmann-Muller, and D Grangé
December 1983, The Journal of clinical psychiatry,
P Vidailhet, and M Kazès, and J M Danion, and F Kauffmann-Muller, and D Grangé
July 1994, Psychopharmacology,
P Vidailhet, and M Kazès, and J M Danion, and F Kauffmann-Muller, and D Grangé
February 1984, Pharmacology, biochemistry, and behavior,
P Vidailhet, and M Kazès, and J M Danion, and F Kauffmann-Muller, and D Grangé
May 2003, Experimental and clinical psychopharmacology,
P Vidailhet, and M Kazès, and J M Danion, and F Kauffmann-Muller, and D Grangé
April 1995, Psychopharmacology,
P Vidailhet, and M Kazès, and J M Danion, and F Kauffmann-Muller, and D Grangé
January 1987, European journal of clinical pharmacology,
P Vidailhet, and M Kazès, and J M Danion, and F Kauffmann-Muller, and D Grangé
March 2002, Consciousness and cognition,
P Vidailhet, and M Kazès, and J M Danion, and F Kauffmann-Muller, and D Grangé
June 2007, Cognitive, affective & behavioral neuroscience,
P Vidailhet, and M Kazès, and J M Danion, and F Kauffmann-Muller, and D Grangé
August 2001, Vision research,
P Vidailhet, and M Kazès, and J M Danion, and F Kauffmann-Muller, and D Grangé
April 1978, Experientia,
Copied contents to your clipboard!